Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Bioequivalence Study of 21 Milligram (mg) Nicotine Transdermal Patches (NicoDerm CQ, GlaxoSmithKline [GSK] Dungarvan) Compared to the Current Marketed 21 mg Nicotine Transdermal Patches (NicoDerm CQ, Alza) in Healthy Adult Smokers

HALEON · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
tobacco use disorder, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 889928
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.